Deprescribing antidepressants: An integral and neglected component of high-quality prescribing practice

Looi JC Allison S Bastiampillai T , et al. (2024) Deprescribing antidepressants for depression - what is the evidence for and against? Australas Psychiatry 10398562241282377.

Horowitz M Taylor D . The Maudsley deprescribing guidelines: antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs [Internet]. 1st ed. Wiley-Blackwell; 2024. 848 p. Available from: https://www.wiley.com/en-ae/The+Maudsley+Deprescribing+Guidelines%3A+Antidepressants%2C+Benzodiazepines%2C+Gabapentinoids+and+Z+drugs-p-9781119823025

OECD . Pharmaceutical market. OECD Data Explorer. https://data-explorer.oecd.org/vis?df[ds]=DisseminateFinalDMZ&df[id]=HEALTH_PHMC%40DF_KEY_INDIC&df[ag]=OECD.ELS.HD&dq=..DDD_10P3HB..N06A&pd=2010%2C&to[TIME_PERIOD]=false&ly[cl]=TIME_PERIOD&ly[rs]=MEASURE&ly[rw]=REF_AREA&vw=tb (accessed November 27, 2024).

Wallis KA Donald M Moncrieff J . Antidepressant prescribing in general practice: a call to action. Aust J Gen Pract 2021; 50(12): 954–956. DOI: 10.31128/AJGP-02-21-5828.

Horowitz M Wilcock M . Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stop. Drug Ther Bull 2022; 60(1): 7–12. DOI: 10.1136/dtb.2020.000080.

NHS England. National medicines optimisation opportunities 2023/24. NHS England. https://www.england.nhs.uk/long-read/national-medicines-optimisation-opportunities-2023-24/#7-addressing-inappropriate-antidepressant-prescribing (accessed August 1, 2023).

NHS England. Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care. NHS England. https://www.england.nhs.uk/long-read/optimising-personalised-care-for-adults-prescribed-medicines-associated-with-dependence-or-withdrawal-symptoms/ (accessed May 29, 2023).

Cruickshank G MacGillivray S Bruce D , et al. Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care. Ment Health Fam Med 2008; 5(2): 105–109, Available from: https://www.ncbi.nlm.nih.gov/pubmed/22477855

Ambresin G Palmer V Densley K , et al. What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study. J Affect Disord [Internet] 2015; 176: 125–132. DOI: 10.1016/j.jad.2015.01.055.

Eveleigh R Muskens E Lucassen P , et al. Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care. BJGP Open [Internet] 2018; 1(4): bjgpopen17X101265. DOI: 10.3399/bjgpopen17X101265.

Davidson SK Romaniuk H Chondros P , et al. Antidepressant treatment for primary care patients with depressive symptoms: data from the diamond longitudinal cohort study. Aust N Z J Psychiatry [Internet] 2020; 54(4): 367–381. Available from: https://journals.sagepub.com/doi/full/10.1177/0004867419898761

Brisnik V Vukas J Jung-Sievers C , et al. Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA appropriateness method. BMC Med [Internet] 2024; 22(1): 193. DOI: 10.1186/s12916-024-03397-w.

Luo Y Kataoka Y Ostinelli EG , et al. National prescription Patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population Representative survey based analysis. Front Psychiatry [Internet] 2020; 11: 35. DOI: 10.3389/fpsyt.2020.00035.

Brett J Karanges EA Daniels B , et al. Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure. Aust N Z J Psychiatry [Internet] 2017; 51(10): 990–999. Available from: https://journals.sagepub.com/doi/full/10.1177/0004867417721018?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org

Kjosavik SR Gillam MH Roughead EE (2016) Average duration of treatment with antidepressants among concession card holders in Australia. Aust N Z J Psychiatry 50: 1180–5.

McHugh RK Whitton SW Peckham AD , et al. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry 2013; 74(6): 595–602. DOI: 10.4088/JCP.12r07757.

Bet PM Hugtenburg JG Penninx BWJH , et al. Side effects of antidepressants during long-term use in a naturalistic setting. Eur Neuropsychopharmacol [Internet] 2013; 23(11): 1443–1451. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0924977X13001454

Serretti A Chiesa A . Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol [Internet] 2009; 29(3): 259–266. DOI: 10.1097/JCP.0b013e3181a5233f.

Updated warnings about persistent sexual dysfunction for antidepressants. Therapeutic Goods Administration (TGA). 2024; published online June 3. https://www.tga.gov.au/news/safety-updates/updated-warnings-about-persistent-sexual-dysfunction-antidepressants (accessed June 3, 2024).

Coupland C Dhiman P Morriss R , et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ [Internet] 2011; 343(aug02 1): d4551. DOI: 10.1136/bmj.d4551.

Laporte S Chapelle C Caillet P , et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies. Pharmacol Res 2017; 118: 19–32. DOI: 10.1016/j.phrs.2016.08.017.

Bakker S Burggraaf JLI Kruip MJHA , et al. Selective serotonin reuptake inhibitor Use and risk of major bleeding during treatment with Vitamin K Antagonists: Results of A cohort study. Thromb Haemost 2023; 123(02): 245–254. Available from: https://pubmed.ncbi.nlm.nih.gov/36208621/

Davies J Read J . A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav 2019; 97(August): 111–121. DOI: 10.1016/j.addbeh.2018.08.027.

Zhang M-M Tan X Zheng Y-B , et al. Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review. Mol Psychiatry 2024; 11: 1–12, Available from: https://scholar.google.com/citations?view_op=view_citation&hl=en&citation_for_view=sEcbBuUAAAAJ:uWQEDVKXjbEC

Henssler J Schmidt Y Schmidt U , et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. Lancet Psychiatr 2024; 11(7): 526–535. DOI: 10.1016/S2215-0366(24)00133-0.

Read J Davies J . Incidence of antidepressant withdrawal symptoms. Lancet Psychiatr 2024; 11(10): 788–789. DOI: 10.1016/S2215-0366(24)00273-6.

Moncrieff J Read J Horowitz MA . The nature and impact of antidepressant withdrawal symptoms and proposal of the discriminatory antidepressant withdrawal symptoms scale (DAWSS). J Affect Disord Rep 2024; 16: 100765, Available from: https://www.sciencedirect.com/science/article/pii/S2666915324000519

Horowitz MA Framer A Hengartner MP , et al. Estimating risk of antidepressant withdrawal from a review of published data. CNS Drugs 2023; 37(2): 143–157. DOI: 10.1007/s40263-022-00960-y.

Lewis G Marston L Duffy L , et al. Maintenance or discontinuation of antidepressants in primary care. N Engl J Med [Internet] 2021; 385(14): 1257–1267. DOI: 10.1056/NEJMoa2106356.

Lewis G Lewis G . Half of people who stopped long term antidepressants relapsed within a year, study finds: Rapid Response. BMJ. 2021; published online Oct 20. DOI: 10.1136/bmj.n2403.

Kuschpel MS . Maintenance or discontinuation of antidepressants in primary care. N Engl J Med; 2021; 385(27): 2587. Available from: https://www.nejm.org/doi/full/10.1056/NEJMc2117168

Horowitz MA Parkin B Moncrieff J . Antidepressant discontinuation trial misleading as it likely mis-interprets withdrawal effects as relapse: Rapid Response. BMJ. https://www.bmj.com/content/374/bmj.n2403/rr-4 (accessed December 19, 2021).